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ID polymorphismAbstract Angiotensin-converting enzyme (ACE), a key enzyme in the renin– angiotensin–aldos-
terone system, converts angiotensin I to angiotensin II. Ethnic origin should be carefully considered
in studies pertaining to ACE I/D genotype and disease etiology. This study was evaluated between
the ACE gene I/D polymorphism and female infertility in the Saudi population. Out of a A total of
300 women who participated in this study genomic DNA samples from the 150 infertile and 150
fertile women’s were isolated who has participated in this study. Genomic DNA was isolated using
an Invitrogen kit according to the manufacturer’s protocol, and D allele speciﬁc primers were used
for ampliﬁcation by polymerase chain reaction. Electrophoresis was carried out on a 2% agarose
gel. The mean age and BMI of the cases and controls were similar (p> 0.05), and a signiﬁcant asso-
ciation was noted between the family history and female infertility (p= 0.0001). The D allele (OR:
1.67 [95% CI: 1.18–2.35], p= 0.003), DD genotype (OR: 2.46 [95% CI: 1.20–5.02], p= 0.01) and
dominant model (OR: 1.97 [95% CI: 1.00–3.88], p= 0.04) were signiﬁcantly associated with female
infertility or fertility. The results of this study show that the ACE polymorphism plays an important
role in female infertility in the Saudi population.
 2016 Production and hosting by Elsevier B.V. on behalf of King Saud University. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Female infertility is a complex disorder that can be caused by
medical conditions such as pelvic inﬂammatory disease,endometriosis, polycystic ovary syndrome (PCOS), premature
ovarian failure, and uterine ﬁbroids (Motovali-Bashi et al.,
2015). The incidence of infertility differs between racial and
ethnic groups because of the multifactorial nature of the dis-
ease. It affects approximately 10% of couples during their
reproductive years. Ovulatory disorders (15%), tuboperitoneal
factors (35%), male factors (35%), unexplained factors (10%),
and both male and female factors (35%) can cause infertility.
Ovulatory disorders are more common in young women,
whereas unexplained infertility occurs more frequently in older
women. Unexplained infertility is diagnosed by the exclusionolymor-
2 J. Al-Mutawaof other causes, and its prevalence ranges from 5% to 37% in
various populations (Karatas et al., 2014). Age, smoking, obe-
sity, alcohol consumption, and family history are all risk fac-
tors for infertility (Seshagiri, 2001). Infertility is deﬁned as
either primary or secondary based on the couple’s history. Pri-
mary infertility is the inability to conceive despite at least
1 year of unprotected intercourse. Secondary infertility is the
inability to become pregnant or carry a pregnancy to term
when a woman has given birth to a child without the assistance
of reproductive medicine in the past (Fatima et al., 2015).
Recurrent Pregnancy loss (RPL) is deﬁned as losing of mini-
mum three or among that as consecutive spontaneous abortion
before the 20th week of gestation (Li et al., 2016). Speciﬁcally,
there is no deﬁnition of RPL since certain aspects (including
number of abortions, consecutive nature of miscarriages, his-
tory of live births and gestational age at pregnancy loss) are
still controversial (Yang et al., 2015). The pregnancy complica-
tions have been found to be related to thrombophilic polymor-
phisms (examples: MTHFR, FVL, ACE and PII), explains
about 30% of obstetrical problems including pregnancy
complications such as RPL (Goodman et al., 2009). Previous
studies have examined the role of the angiotensin-converting
enzyme-1 (ACE1) gene in male and female infertility factors
including PCOS and endometriosis (Hsieh et al., 2007; Jia
et al., 2013; Kowalczyn´ska et al., 2014; Kucera et al., 2001;
Zalata et al., 2012). PCOS is the leading cause of ovulatory
infertility, affecting 5–7% of women of reproductive age, and
the renin–angiotensin system (RAS) activity in PCOS suggests
an important correlation between the RAS and PCOS.
ACE1/male mice have been found to be sterile, and despite
the sperm motility and fusing location of eggs generated in
Ace2/ and Ace3/ mice, the male mice were slightly
abnormal, and both knockouts proved to be fertile. These facts
indicate that ACE1, ACE2, and angiotensin-converting
enzyme-3 (ACE3) may be among the mechanisms responsible
for infertility (Pan et al., 2013). ACE is a zinc metallopeptidase
widely distributed on the surface of endothelial and epithelial
cells. It converts the inactive decapeptide angiotensin I (Ang
I or Ang 1–10) to the active octapeptide and potent vasocon-
strictor angiotensin II (Ang II or Ang 1–8), which is the main
active product of the renin–angiotensin system (RAS). The
importance of functional polymorphism of the ACE gene
(I/D polymorphism) was discovered through its association
with plasma ACE levels (Sayed-Tabatabaei et al., 2006). The
insertion and deletion (I/D) polymorphism of the
angiotensin-converting enzyme (ACE: NM 000789.2) gene is
the ﬁrst genetic variant associated with human physical perfor-
mance and is in strong linkage disequilibrium with genetic fac-
tors that inﬂuence serum ACE concentrations (Kowalczyn´ska
et al., 2014; Poornima et al., 2015). The ACE1 gene consists of
26 exons and 25 introns appearing on chromosome 17q23. The
ACE gene contains a 287-bp Alu sequence in the 16th intron
region (Hsieh et al., 2007; Shanmuganathan et al., 2015).
The rs4646994 polymorphism in the ACE gene is characterized
by the presence or absence of a 287-bp Alu repetitive sequence,
resulting in the II, ID, and DD genotypes (Pan et al., 2013;
Zhao et al., 2015). Earlier studies have shown that DD
homozygotes have an approximately twofold higher level of
tissue and plasma ACE as compared to II homozygotes
(Pradhan et al., 2015; Sayed-Tabatabaei et al., 2006). Based
on previous reports, this study was evaluated between thePlease cite this article in press as: Al-Mutawa, J. Interaction with angiotensin-conver
phism studies. Saudi Journal of Biological Sciences (2016), http://dx.doi.org/10.1016ACE gene I/D polymorphism and female infertility in the
Saudi population.
2. Materials and methods
2.1. Selection of subjects
This was a hospital-based study carried out by the Department
of Obstetrics and Gynecology at the King Khalid University
Hospitals (KKUH) in Riyadh and Saudi Arabia. The study
took place from January 2015 to November 2015. A total of
300 samples were recruited and 150 infertile women as well
as 150 fertile women served as control subjects for this study.
The cases were recruited based on their (i) family history of fer-
tility and (ii) inability to conceive for more than 3 years. The
infertility cases were examined based on hormonal and bio-
chemical analysis, sexually transmitted diseases, hysterosalpin-
gography, hysteroscopy, laparoscopy, and genetic
immunological abnormalities, as well as semen analysis of
the partner. The control subjects were conﬁrmed to have con-
ceived without assisted reproductive techniques and were
selected based on (i) regular menstrual cycles, (ii) conception
of a minimum of one child, and (iii) without family history
of infertility. Control subjects with ovarian lesions/
endometriosis and family histories of infertility were excluded.
Women with endometriosis, Mu¨llerian defects, autoimmune
diseases, ovulatory or endocrine disorders, or partners who
had male factors such as low sperm count were also excluded
as controls. The ethical approval was obtained for this study
from KKUH.
2.2. Blood analysis
Four milliliters of peripheral blood were collected from each
patient in EDTA vacutainers, and genomic DNA was
extracted with an Invitrogen kit (PureLink Genomic DNA
Kit; Thermo Fischer Scientiﬁc, MA, USA). The genomic
DNA was separated from the lymphocytes as per the manufac-
turer’s instructions. The quantiﬁcation of DNA was performed
by NanoDrop spectrophotometer analysis (NanoDrop 2000;
Thermo Fischer Scientiﬁc, MA, USA). The oligonucleotide
sequence (forward and reverse primers) for the insertion and
deletion polymorphism of the ACE gene was selected from ear-
lier studies (Khan et al., 2014; Poornima et al., 2015). The
genotyping for ACE gene I/D polymorphism was accom-
plished by direct PCR followed by 2% agarose gel elec-
trophoresis. The 190 bp fragment indicates the deletion allele
and the 490 bp fragment indicates the insertion allele.
Heterozygous results showed both 490 and 190 bp fragments.
The PCR program was performed as follows: initial denatura-
tion at 95 C for 5 min; 35 cycles of denaturation at 95 C for
30 s, annealing at 58 C for 30 s, and extension at 72 C for
45 s; and ﬁnal extension at 95 C for 5 min (see Table 1).
2.3. Statistical analysis
The genotype and allele frequencies between infertility and fer-
tility women were calculated with odds ratio (OR), followed by
95% conﬁdence intervals (CI’s) and p values. The chi-square
(v2) analysis was calculated between cases and controls. Theting enzyme-encoding gene in female infertility: Insertion and deletion polymor-
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Table 1 Characteristics of selected subjects and controls







Age (Years) 32.1 ± 2.4 31.7 ± 2.3 0.11
BMI (kg/m2) 33.5 ± 2.7 33.2 ± 2.5 0.18
Women eﬀected with
infertility
150 (100%) 0 (0%) 0.0001
Family history of
infertility
81 (54%) 0 (0%) 0.0001
Angiotensin-converting enzyme gene with Insertion-Deletion polymorphism studies 3statistical analysis was carried out using statistical package for
the social sciences, version 22.0 for Windows (SPSS Inc., Chi-
cago, IL, USA). v2 test for goodness of ﬁt was used to calculate
the agreement of the observed genotype frequencies with those
expected according to the Hardy–Weinberg equilibrium
(HWE). The clinical data were expressed as mean ± standard
deviation (SD). The p value which is less than 0.05 was indi-
cated as signiﬁcant association.3. Results
For this study, 300 subjects were selected, including 150 infer-
tile women (cases) and 150 fertile women (controls). The mean
age of the cases was 32.1 ± 2.4 years, and the mean age of the
controls was 31.7 ± 2.3 years. The ages and BMIs of both
groups were found to be similar (p> 0.05). All the cases were
affected by infertility and a statistical signiﬁcant was found
between the cases and controls (p< 0.05). The family history
was found in the 54% of the cases and none of them in the con-
trols, associated positively in both the cases and controls
(p< 0.05). The allelic frequency and genotype distribution
of the ACE polymorphism is associated with infertility in
women. The genotype distributions of the I/D polymorphism
in the infertile cases and fertile controls are shown in Table 2.
The genotype frequencies of II, ID, and DD in infertile women
were 10%, 35.3% and 54.7%, respectively. The percentage ofTable 2 Genotype and allele frequencies between cases and contro
Genotypes Cases (n= 150) Controls (n= 150)
II 15 (10%) 27 (18%)
ID 53 (35.3%) 63 (42%)
DD 82 (54.7%) 60 (40%)
I 83 (0.28) 117 (0.39)
D 217 (0.72) 183 (0.61)
Table 3 Different model of statistical analysis with the cases and c
Model Cases (%) Controls (%)
Dominant 15 (10%) 27 (18%)
Co-dominant 53 (35.3%) 63 (42%)
Recessive 82 (54.7%) 60 (40%)
Please cite this article in press as: Al-Mutawa, J. Interaction with angiotensin-conver
phism studies. Saudi Journal of Biological Sciences (2016), http://dx.doi.org/10.1016the D allele was 0.72%, and the percentage of the I allele
was 0.28% among the infertile cases. The genotype distribu-
tions of II, ID, and DD in normal subjects were 18%, 42%,
and 40% respectively. The allelic frequencies of the D and I
alleles in the control subjects were 0.61% and 0.39%, respec-
tively. The genotype frequencies of the I/D polymorphism
were consistent with HWE in the study group. The statistical
analysis of genotype results indicated that DD vs. II (OR:
2.46 [95% CI: 1.20–5.02], p= 0.01), and DD+ ID vs. II
(OR: 1.97 [95% CI: 1.00–3.88], p= 0.04) of the cases and con-
trols was signiﬁcantly associated. The allele frequencies of the
cases and controls were statistically associated as well (D vs. I,
OR: 1.67 [95% CI 1.18–2.35], p= 0.003) (Table 3).
4. Discussion
There are no prior or current studies carried out with female
infertility and ACE gene I/D polymorphism in any ethnic
groups. The aim of the present study was to identify the asso-
ciation between the ACE gene I/D polymorphism and female
infertility in the Saudi population. To the knowledge, this is
the ﬁrst such study to be carried out on this topic in infertile
female subjects in Saudi Arabia. The results showed a positive
association within the alleles and genotypes (p< 0.05). The
dominant and recessive models also showed a statistical asso-
ciation. Age vs. genotypes and BMI vs. genotypes showed an
insigniﬁcant association among the cases (p> 0.05).
Infertility has become a global problem affecting 15% of
couples having unprotected intercourse; it affects males and
females equally. Idiopathic infertility is diagnosed when cou-
ples are unable to conceive for more than 2 years, with no
abnormalities found during repeated investigations of tubes
or in ovulation, the luteal phase, cervical mucus, semen,
sperm–oocyte interaction, or intercourse. The major genetic
causes of infertility are chromosomal abnormalities,
microdeletions, chromosomal abnormalities, cystic ﬁbrosis
transmembrane conductance regulator mutations, follicle stim-
ulation hormone receptor mutations, and other genetic factors.
The major causes of infertility in women are ovulation disor-
ders and tubal damage, which account for 50% of the cases.
Endometriosis, hyperprolactinemia, and reproductive tractl subjects.
p Value OR (95% CI) X2
Reference
0.26 1.51 (0.73–3.14) 1.24
0.01 2.46 (1.20–5.02) 6.27
Reference
0.003 1.67 (1.18–2.35) 8.65
ontrols.
X2 OR (95% CI) p Value
3.97 1.97 (1.00–3.88) 0.04
1.40 1.32 (0.83–2.11) 0.23
6.45 0.55 (0.34–0.87) 0.001
ting enzyme-encoding gene in female infertility: Insertion and deletion polymor-
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4 J. Al-Mutawadiseases are other causes of infertility in women. The other
major risk factors affecting female fertility are pelvic inﬂam-
matory disease, sexually transmitted diseases, damaged Fal-
lopian tubes, pelvic surgery, ectopic pregnancy, and unsafe
abortions. Additionally, it has been reported that cigarette
smoking can lead to tubal diseases and abnormal cervical
mucus, resulting in an increased risk of infertility and child-
hood cancers (Ferlin et al., 2006; Zenzes, 2000).
ACE plays a critical role in the RAS, involved in the con-
version of angiotensin I to active angiotensin II, a potent vaso-
pressor. ACE also has a physiological function in the
ﬁbrinolysis pathway as it regulates the concentrations of plas-
minogen activator Inhibitor I (PAI-1), an important determi-
nant in the control of the ﬁbrinolytic process. The
appearance of D or DD allele/genotype was correlated with
elevated plasma and tissue-speciﬁc ACE activity and the dele-
tion genotype (DD) also enriches production of angiotensin II
from angiotensin I, is associated with high levels of circulating
PAI-1, which result in reduced levels of ﬁbrinolysis. The
mutant of D allele in the ACE gene may compromise placental
formation and trophoblastic invasion because of increased
PAI-1 expression and concomitant reduced ﬁbrinolytic activity
(Su et al., 2013). The gravidas with thrombophilic defects, risks
for pregnancy-associated thromboembolism, and other vascu-
lar complications, such as pre-eclampsia and abortion, will be
improved (Yang et al., 2012). Earlier studies carried out with
ACE gene I/D polymorphism studies with RPL failed to show
the association in different ethnicities (Bagheri et al., 2010;
Goodman et al., 2009; Vettriselvi et al., 2008) and it was sup-
ported by one of the meta-analysis studies by Yang et al.
(2012) carried out in Asian and Caucasian populations. How-
ever, Su et al. (2013) meta-analysis study revealed the positive
association in RPL. The present study is in accordance with
the Su et al. (2013) studies.
The association between genetic polymorphisms and clini-
cal disease has long been recognized. Many aspects of female
reproductive function are strongly inﬂuenced by genetic fac-
tors, and numerous studies have attempted to identify suscep-
tibility genes for disorders affecting female fertility (Tempfer
et al., 2009). The associations between several polymorphisms
in the human genome and the infertility of women with
endometriosis have been demonstrated.(Kowalczyn´ska et al.,
2011) The ACE gene has a signiﬁcant association with male
infertility and the ID polymorphism (Kucera et al., 2001;
Zalata et al., 2012). The strength of our current study was its
recruitment of women between the ages of 20 and 40 years,
since strong evidence suggests that couples who are trying to
conceive become less fertile as they age. The failure to measure
ACE levels was the one of the limitations of this study.
Results of current study indicate that the ACE polymor-
phism plays an important role in female infertility in the Saudi
population. Additional studies are needed to explore this rela-
tionship in more detail in subjects with primary or secondary
infertility.
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